• Overview
  • Eligibility
  • More info
  • Locations

Molecular and Genetic Analysis of Lung Cancer (NCT03029325)

National Cancer Institute (NCI)
Investigators use a genome-wide approach within a case-control design to identify SNPs that show evidence of association with lung cancer risk and survival.
Ages eligible for Study
18 Years and older
Genders eligible for Study
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Inclusion Criteria:
  • healthy controls: participants without evidence of any cancer
  • cases: pathology proven primary lung cancer
Exclusion Criteria:
  • younger than 18 years old
Investigators also investigate how genetic variants may affect cancer treatment, at various stages of disease development, in order to determine prognostic and predictive factors for survival.

1 locations

United States (1)
  • Massachusetts General Hospital
    recruiting
    Boston, Massachusetts, United States, 02114
Status:
recruiting
Type:
Observational
Phase:
-
Start:
31 May, 1993
Updated:
19 January, 2017
Participants:
10000
Apply
A girl giving information about available additional trials.

FindMeCure helps you find, understand and join clinical trials from all over the world.

There are more clinical trials for your condition!